Janux Therapeutics JANX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's net income?
- Janux Therapeutics (JANX) reported net income of -$24.36M in Q1 2026.
- How has Janux Therapeutics's net income changed year-over-year?
- Janux Therapeutics's net income decreased by 3.6% year-over-year, from -$23.51M to -$24.36M.
- What is the long-term trend for Janux Therapeutics's net income?
- Over 4 years (2021 to 2025), Janux Therapeutics's net income has grown at a 36.6% compound annual growth rate (CAGR), from -$32.67M to -$113.63M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.